- Home
- PXS vs BRNS Comparison
PXS vs BRNS Comparison
Compare PXS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PXS
- BRNS
- Stock Information
- Founded
- PXS 2015
- BRNS 2016
- Country
- PXS Greece
- BRNS United Kingdom
- Employees
- PXS N/A
- BRNS N/A
- Industry
- PXS Marine Transportation
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- PXS Consumer Discretionary
- BRNS Health Care
- Exchange
- PXS Nasdaq
- BRNS Nasdaq
- Market Cap
- PXS 30.2M
- BRNS 40.0M
- IPO Year
- PXS N/A
- BRNS 2021
- Fundamental
- Price
- PXS $2.80
- BRNS $0.90
- Analyst Decision
- PXS Strong Buy
- BRNS Strong Buy
- Analyst Count
- PXS 1
- BRNS 1
- Target Price
- PXS $10.00
- BRNS $3.00
- AVG Volume (30 Days)
- PXS 55.0K
- BRNS 12.7K
- Earning Date
- PXS 08-11-2025
- BRNS 08-07-2025
- Dividend Yield
- PXS N/A
- BRNS N/A
- EPS Growth
- PXS N/A
- BRNS N/A
- EPS
- PXS 0.63
- BRNS N/A
- Revenue
- PXS $49,342,000.00
- BRNS $14,969,000.00
- Revenue This Year
- PXS N/A
- BRNS N/A
- Revenue Next Year
- PXS $31.36
- BRNS N/A
- P/E Ratio
- PXS $4.48
- BRNS N/A
- Revenue Growth
- PXS 8.07
- BRNS 4381.74
- 52 Week Low
- PXS $2.53
- BRNS $0.64
- 52 Week High
- PXS $5.53
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- PXS 48.10
- BRNS 50.69
- Support Level
- PXS $2.78
- BRNS $0.83
- Resistance Level
- PXS $3.16
- BRNS $0.95
- Average True Range (ATR)
- PXS 0.15
- BRNS 0.05
- MACD
- PXS 0.01
- BRNS -0.01
- Stochastic Oscillator
- PXS 35.96
- BRNS 45.35
About PXS Pyxis Tankers Inc.
Pyxis Tankers Inc is an international maritime transportation company focused on mid-sized eco-vessels for the product tanker and dry-bulk sectors. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Konkar Ormi, Pyxis Lamda, Konkar Venture, Pyxis Karteria, and others. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals. The company operates under two reportable segments, Tanker Vessels, which derive maximum revenue, and Dry-bulk Vessels.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.